We are concerned that a failure of clinicians to adequately mitigate risk…has resulted in prescription opioids having essentially been ‘litigated away’—resulting in widespread opiophobia...
MONTCLAIR, N.J. (PRWEB) April 08, 2019
PAINWeekEnd on May 4 at the St. Louis Union Station Hotel, 1820 N. Market St., in Missouri, will be a timely full day program providing busy clinicians and allied healthcare practitioners with 6.0 hours of relevant, practical instruction in the management of chronic pain.
Missouri is the only state in the nation that has not established a prescription drug monitoring program, although a 6th attempt passed the House of Representatives in February of this year. A companion bill currently awaits action in the state senate that, if passed and signed by Governor Mike Parson, who has expressed support, would authorize the Department of Health and Human Services to establish a PDMP with a proposed effective date of August 8, 2019. As currently written, use of the PDMP by prescribers would not be mandatory at this time. Past opposition to the legislation has centered on information privacy concerns, but also on the potential for adversely impacting pain patients’ access to care. At PAINWeekEnd St. Louis, senior faculty member Michael Schatman, PhD, CPE, DASPE, will present Opioid Moderatism and Rapprochement: The Search for a Sane Middle Ground. In a recent article in the Journal of Pain Research, Dr. Schatman wrote, “We are concerned that a failure of clinicians to adequately mitigate risk…has resulted in prescription opioids having essentially been ‘litigated away’—resulting in widespread opiophobia and oligoanalgesia. Few argue for a return to patterns of reckless prescribing that was one of the root causes of the prescription opioid crisis. However, a more moderatist approach needs to be considered if the opioid pendulum is to ever find a safe yet humane resting place.” Dr. Schatman will also present Reefer Madness Revisited, a review of what we know—and what we don’t know—about the efficacy and safety of medical cannabinoids.
Other courses to be offered at PAINWeekEnd St. Louis include The Regulatory Agency Will See You Now; Nonopioid Analgesics: Antidepressants, Adjuvant Therapies, and Muscle Relaxants; Pain, Drugs, and Ethics; and Rational Polypharmacy: An Update for Specific Conditions. Commercially supported activities—addressing a range of product, disease state, and medical information topics—will also be presented.
For more information about this or other regional conferences, and to register for $129, go to the https://www.painweek.org/conferences/painweekend/st-louis-mo-2019-conference website. BONUS: PAINWeekEnd registrants may register for the 2019 PAINWeek National Conference, September 3-7, in Las Vegas, for $200 off the regular online published price.
PAINWeekEnd is provided by Global Education Group. About Global Education Group:
Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.